0RPS Stock Overview
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 4/6 |
Past Performance | 4/6 |
Financial Health | 1/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Medicover AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr132.20 |
52 Week High | kr186.20 |
52 Week Low | kr119.30 |
Beta | 1.51 |
1 Month Change | -2.25% |
3 Month Change | -22.86% |
1 Year Change | -24.94% |
3 Year Change | -44.45% |
5 Year Change | 64.63% |
Change since IPO | 101.85% |
Recent News & Updates
Recent updates
Shareholder Returns
0RPS | GB Healthcare | GB Market | |
---|---|---|---|
7D | -1.2% | 1.9% | -0.9% |
1Y | -24.9% | -29.5% | -1.8% |
Return vs Industry: 0RPS exceeded the UK Healthcare industry which returned -29.5% over the past year.
Return vs Market: 0RPS underperformed the UK Market which returned -1.8% over the past year.
Price Volatility
0RPS volatility | |
---|---|
0RPS Average Weekly Movement | 4.5% |
Healthcare Industry Average Movement | 7.4% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.3% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0RPS's share price has been volatile over the past 3 months.
Volatility Over Time: 0RPS's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1995 | 45,316 | Fredrik Rågmark | www.medicover.com |
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company’s Healthcare services includes service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness services; hospital care; and preventive care. Its Diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology.
Medicover AB (publ) Fundamentals Summary
0RPS fundamental statistics | |
---|---|
Market cap | kr19.78b |
Earnings (TTM) | kr204.21m |
Revenue (TTM) | kr20.26b |
96.9x
P/E Ratio1.0x
P/S RatioIs 0RPS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0RPS income statement (TTM) | |
---|---|
Revenue | €1.75b |
Cost of Revenue | €1.39b |
Gross Profit | €359.40m |
Other Expenses | €341.80m |
Earnings | €17.60m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 26, 2024
Earnings per share (EPS) | 0.12 |
Gross Margin | 20.58% |
Net Profit Margin | 1.01% |
Debt/Equity Ratio | 106.9% |
How did 0RPS perform over the long term?
See historical performance and comparisonDividends
1.1%
Current Dividend Yield102%
Payout RatioDoes 0RPS pay a reliable dividends?
See 0RPS dividend history and benchmarksMedicover dividend dates | |
---|---|
Ex Dividend Date | Apr 29 2024 |
Dividend Pay Date | May 06 2024 |
Days until Ex dividend | 5 days |
Days until Dividend pay date | 12 days |
Does 0RPS pay a reliable dividends?
See 0RPS dividend history and benchmarks